[Study on clinical efficacy and mechanism of Qingying Tang for treating psoriatic blood-heat syndrome based on IL-23/Th17].

医学 皮肤科生活质量指数 银屑病 胃肠病学 银屑病面积及严重程度指数 内科学 白细胞介素17 中医药 病变 血脂 皮肤病科 外科 病理 细胞因子 胆固醇 替代医学
作者
Li Wang,Yu-Pu Fang,Guo-xiu Zhou,Panhong Wu,Qing-Juan Li,Geng Qian
出处
期刊:PubMed 卷期号:44 (1): 175-180 被引量:6
标识
DOI:10.19540/j.cnki.cjcmm.20180709.001
摘要

To observe the clinical curative effect of Qingying Tang in the treatment of psoriatic blood-heat syndrome and explore its intrinsic mechanism.In this study,we collected 72 patients with blood-heat syndrome psoriasis admitted to our dermatology clinic from January 2016 to December 2017 and divided into control group and observation group according to the random number table method,36 cases in each group.The patients in control group were given with Acitretin Capsules orally,10 mg/time,twice a day.The patients in observation group were given with Qingying Tang orally,150 mL/time,twice a day.The treatment period was 12 weeks in both groups.The traditional Chinese medicine(TCM) syndrome scores before and after treatment,psoriasis area and severity index(PASI) score,dermatology life quality index(DLQI) score,and the clinical efficacy of the two groups were compared between the two groups;flow cytometry was used to detect peripheral blood Th17 cell percentages before and after treatment in both groups;serum interleukin(IL)-17,IL-23,IL-22,and IL-21 levels in both groups before and after treatment were measured by ELISA;the expression levels of STAT3 and RORγt before and after treatment in patients were measured by using skin lesion immunohistochemical method.The results showed that the TCM symptoms were improved significantly in both groups(P<0.05),and the effect in observation group was significantly better than that in the control group(P<0.05).PASI and DLQI scores were decreased significantly after treatment in both groups(P<0.05),and the scores in observation group were significantly lower than those in the control group(P<0.05).The curative effect of the observation group was significantly higher than that of the control group(P<0.05).After treatment,the percentage of Th17 cells,as well as IL-17,IL-23,IL-22 and IL-21 levels in peripheral blood were significantly decreased in both groups(P<0.05),and the levels in observation group were significantly lower than those in the control group(P<0.05).The expression levels of STAT3 and RORγt in both groups were significantly lower than those before treatment(P<0.01),and the levels in observation group were significantly lower than those in the control group(P<0.05).All of the results indicted that Qingying Tang can effectively improve the skin lesions and TCM syndrome in patients with psoriasis and blood-heat syndrome,and improve patient health quality,which may be related to regulation of peripheral blood IL-23/Th17.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助YunRyan采纳,获得10
1秒前
拼搏诗翠发布了新的文献求助10
1秒前
酷波er应助wrf采纳,获得10
2秒前
亚尔发布了新的文献求助10
2秒前
砼姩发布了新的文献求助10
2秒前
2秒前
3秒前
自由远航发布了新的文献求助10
3秒前
以利沙发布了新的文献求助10
3秒前
Akim应助半导体物理采纳,获得10
4秒前
赘婿应助111采纳,获得10
4秒前
楚轩发布了新的文献求助10
4秒前
ccc完成签到,获得积分10
5秒前
科目三应助流光云集采纳,获得10
7秒前
Twonej应助xmh556采纳,获得10
8秒前
CipherSage应助生生采纳,获得10
9秒前
9秒前
10秒前
10秒前
科研通AI6.1应助瘦瘦不斜采纳,获得10
10秒前
山有木兮完成签到,获得积分10
10秒前
彭于晏应助半夏采纳,获得10
11秒前
11秒前
MiPO完成签到,获得积分20
11秒前
在水一方应助Rita采纳,获得10
12秒前
12秒前
13秒前
豆觉子完成签到,获得积分10
13秒前
娄某发布了新的文献求助10
14秒前
浩然发布了新的文献求助10
14秒前
koki发布了新的文献求助30
15秒前
山有木兮发布了新的文献求助10
15秒前
15秒前
谨慎的夏槐应助莹莹啊采纳,获得10
15秒前
淡淡醉波wuliao完成签到 ,获得积分10
15秒前
16秒前
火山完成签到,获得积分20
16秒前
17秒前
可乐发布了新的文献求助10
17秒前
李正洋发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Digital Twins of Advanced Materials Processing 2000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6040568
求助须知:如何正确求助?哪些是违规求助? 7777009
关于积分的说明 16231248
捐赠科研通 5186669
什么是DOI,文献DOI怎么找? 2775483
邀请新用户注册赠送积分活动 1758574
关于科研通互助平台的介绍 1642194